Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

CHANTER Syndrome: Have We Been Overlooking This Catastrophic Opioid Neurotoxicity?

Author:Ghani, Mohammad   Yousaf, Muhammad   Kemper, Nicholas   Shi, Ping   Sagi, Vishwanath   

Session Name:P9: Neurocritical Care: Critical Care Complications  

Topic:Neurocritical Care  

Program Number:P9.002  

Author Institution:University of Louisville School Of Medicine, Louisville, KY  University of Louisville, Louisville, KY  

Multiple Cranial Neuropathies with Orbital Myositis as an Initial Presentation of Lyme Disease

Author:Biso, Grace Marie   Philip, Karan   Chevula, Pradeep   El-Dokla, Ahmed   

Session Name:P9: Infectious Disease: Spirochetes 1  

Topic:Infectious Disease  

Program Number:P9.002  

Author Institution:SUNY Upstate Medical University, Syracuse, NY  SUNY Upstate Medical University, East Syracuse, NY  

Case Series of Nitrous Oxide Related Subacute Combined Degeneration from 2016 to 2022

Author:Warren, William   Taylor, Reid   Savage, Jennie   

Session Name:P9: General Neurology: Deficiency and Toxicity  

Topic:General Neurology  

Program Number:P9.002  

Author Institution:MAHEC, Asheville, NC  Mission Neurology Services, Asheville, NC  Mission Neurology, Asheville, NC  

Urinary Symptom Profile in Early Multiple System Atrophy

Author:Iregui, Jessie   Wynn, Amy   Hay, Kaitlyn   Wong, Cynthia   Stamler, David   Claassen, Daniel   

Session Name:P9: Autonomic Disorders 2  

Topic:Autonomic Disorders  

Program Number:P9.002  

Author Institution:Vanderbilt University Medical Center, Nashville, TN  Alterity Therapeutics, Newark, CA  

Postpartum Relapse Patterns Among Multiple Sclerosis Patients with Exposure to Disease Modifying Therapy Before or During Pregnancy

Author:Bove, Riley   Applebee, Angela   Bawden, Katrina   Fine, Celeste   Shah, Anna   Avila, Robin   Belviso, Nicholas   Branco, Filipe   Fong, Kinyee   Lewin, James   Liu, Jieruo   England, Sarah   Vignos, Megan   

Session Name:P9: MS Special Populations  

Topic:MS and Inflammatory Disease  

Program Number:P9.002  

Author Institution:Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA  Department of Neurology, St. Peter’s MS and Headache Center, Albany, NY  Rocky Mountain MS Clinic, Salt Lake City, UT  Gilbert Neurology, Gilbert, AZ  University of Colorado, Rocky Mountain MS Center, Aurora, CO  Biogen Inc., Cambridge, MA